OBJECTIVES
In patients with axial spondyloarthritis (axSpA) initiating their first tumor necrosis factor alpha-inhibitor (TNFi), we a
|
To evaluate the influence of the disease activity on radiographic progression in axial spondyloarthritis (axSpA) patients treated with
|
Multicenter study, Medicine, Internal medicine, In patient, Disease activity, C-reactive protein, Axial spondyloarthritis, Ankylosin
|
Therapeutic decision making, Retrospective cohort study, Medicine, Internal medicine, In patient, Disease, Clinical diagnosis, BASDA
|
|
|
Back Pain, Blood Sedimentation, Cross-Sectional Studies, Humans, Questionnaires, Severity of Illness Index, Spondylitis, Ankylosing,
|
Quality-adjusted life year, Medicine, In patient, Family medicine, Cost effectiveness, Cohort, BASFI, BASDAI, Axial spondyloarthriti
|
Secukinumab, Retrospective cohort study, Physical therapy, Medicine, Golimumab, Cohort study, Cohort, BASFI, BASDAI, Ankylosing spon
|
Limited information is available on the impact of treatment with a tumor necrosis factor inhibitor (TNFi) structural lesions in patien
|
Background: According to international recommendations, the Ankylosing Spondylitis Disease Activity Score (ASDAS) is preferred score f
|
Background: According to international recommendations, the Ankylosing Spondylitis Disease Activity Score (ASDAS) is preferred score f
|
|
|
Significant difference, Medicine, Internal medicine, In patient, Erythrocyte sedimentation rate, Disease activity, Clinical trial, C
|
Observational study, Medicine, Internal medicine, Enthesitis, Disease, Cohort, CHAID, Body mass index, BASDAI, Ankylosing spondyliti
|
|
|
|
|
Sat-477 : Early ASDAS criteria responsiveness is related with metrology improvements in ankylosing spondylitis
|
Rheumatology, Psoriatic arthritis, Medicine, Internal medicine, Erythrocyte sedimentation rate, Disease burden, Context (language us
|
|
|
Quality of life, Psychometrics, Psoriasis, Peripheral, Medicine, Internal medicine, Disease, Construct validity, Axial spondyloarthr
|
|
